Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, December 18, 2012
Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, today announced that it has completed its acquisition of Banner Pharmacaps ("Banner"), a specialty pharmaceutical business ...
read more
Wolfe Laboratories, Inc. has announced the expansion of its senior management team through the addition of Paul Oakley, who has joined as Senior Vice President and General Counsel.
read more
Avet Pharmaceuticals is initiating a voluntary recall of the following lots of Tetracycline HCl Capsules USP, 250 mg and 500 mg, 100-count bottles.
read more
Thursday, October 07, 2021
Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of RxDataScience, a leading healthcare-focused data analytics, data management and artificial intelligence (AI) company....
read more
Evotec has launched its accelerated drug development service INDiGO.
read more
US Bioservices, a specialty pharmacy that is a part of AmerisourceBergen, announced today it has been selected by Rigel Pharmaceuticals to dispense TAVALISSE™ (fostamatinib disodium hexahydrate) Tablets.TAVALISSE™ was approved by the U.S. Food and ...
read more
Bespak announced the completion of the transaction to separate Recipharm’s former Advanced Delivery Systems Business Unit from the Recipharm Group to form a new standalone company. Both Bespak and Recipharm are backed by EQT Private Equity.
read more
Zymeworks has earned a milestone payment from Merck achieved under the companies’ 2014 research and license agreement.
read more
Tuesday, October 22, 2019
UPS announced numerous new technology-enabled services and partnerships.
read more
Wednesday, December 04, 2019
Catalent has entered into a partnership with Ethicann, a Calgary-based pharmaceutical company using botanically sourced cannabinoid oils to formulate prescription drugs.
read more
CordenPharma announced the signing of an amendment to their existing manufacturing agreement with Moderna to create a new generation of transformative medicines for patients.
read more
Monday, February 13, 2017
Ferring Pharmaceuticals and Foresee Pharmaceuticals have entered into an exclusive worldwide development and option agreement to leverage Foresee’s proprietary and unique Stabilized Injectable Formulation platform (SIF) for the development of long ...
read more
Wednesday, October 08, 2025
Recipharm has designated its Cuxhaven, Germany facility as a Centre of Excellence for analytical services supporting advanced therapy medicinal products (ATMPs) and biologics. The site now operates 500 m² of CGMP-compliant laboratories designed to ...
read more
InveniAI® LLC, has announced the appointment of Salvatore (Salvo) Alesci, M.D., Ph.D., as its Chief Scientific Officer.
read more
ChromaCode announced that the FDA has granted EUA of ChromaCode's HDPCR™ SARS-CoV-2 Real-Time PCR Assay.
read more